Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study
Authors:
- Fiorella KrappFKFiorella Krapp
- Coralith GarcíaCGCoralith García
- Noemi HinostrozaNHNoemi Hinostroza
- Lizeth AstocondorLALizeth Astocondor
- Claudia R. RondonCRClaudia R. Rondon
- Brecht IngelbeenBIBrecht Ingelbeen
- Hugo A. Alpaca-SalvadorHAHugo A. Alpaca-Salvador
- Catherine AmaroCACatherine Amaro
- Carla Aguado VenturaCVCarla Aguado Ventura
- Evelyn Barco-YaipénEBEvelyn Barco-Yaipén
- Cesar Bocangel FernandezCFCesar Bocangel Fernandez
- Alexander BrionesABAlexander Briones
Open Access
- 1 November 2023
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (5) , 1095-1106
Abstract
: Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.Keywords
This publication has 24 references indexed in Scilit:
- Clinical bacteriology in low-resource settings: today's solutionsThe Lancet Infectious Diseases, 2018
- Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line AgentsClinical Infectious Diseases, 2018
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine, 2017
- Antimicrobial resistance—a threat to the world’s sustainable developmentUpsala Journal of Medical Sciences, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Stratification of the Impact of Inappropriate Empirical Antimicrobial Therapy for Gram-Negative Bloodstream Infections by Predicted PrognosisAntimicrobial Agents and Chemotherapy, 2015
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Identification of Acinetobacter baumannii by Detection of the bla OXA-51-like Carbapenemase Gene Intrinsic to This SpeciesJournal of Clinical Microbiology, 2006
- Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentaryInternational Journal of Antimicrobial Agents, 1999